HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Verlinden Selected Research

Alemcinal

9/2001Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.
12/2000Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial.
4/2000The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Verlinden Research Topics

Disease

3Heartburn (Pyrosis)
09/2001 - 04/2000
2Nausea
09/2001 - 03/2001
2Dyspepsia (Indigestion)
03/2001 - 12/2000
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2001
1Diabetes Mellitus
09/2001
1Pain (Aches)
03/2001
1Gastroesophageal Reflux (GERD)
04/2000

Drug/Important Bio-Agent (IBA)

3AlemcinalIBA
09/2001 - 04/2000
3MotilinIBA
09/2001 - 04/2000
2motilin receptorIBA
09/2001 - 12/2000
2Cisapride (Propulsid)FDA Link
03/2001 - 04/2000
1AcidsIBA
09/2001
1Domperidone (Domperidon)IBA
03/2001